(Q30403078)

English

Dose-sparing H5N1 A/Indonesia/05/2005 pre-pandemic influenza vaccine in adults and elderly adults: a phase III, placebo-controlled, randomized study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

6 November 2017

Dose-sparing H5N1 A/Indonesia/05/2005 pre-pandemic influenza vaccine in adults and elderly adults: a phase III, placebo-controlled, randomized study (English)

1 reference

Europe PubMed Central

PMC publication ID

6 November 2017

0 references

0 references

0 references

influenza vaccine

1 reference

based on heuristic

inferred from title

11

1 reference

Europe PubMed Central

PMC publication ID

6 November 2017

Joanne M. Langley

object named as

Joanne M Langley

1

0 references

Louise Frenette

10

object named as

Louise Frenette

1 reference

Europe PubMed Central

PMC publication ID

6 November 2017

author name string

George Risi

2

1 reference

Europe PubMed Central

PMC publication ID

6 November 2017

Michael Caldwell

3

1 reference

Europe PubMed Central

PMC publication ID

6 November 2017

Larry Gilderman

4

1 reference

Europe PubMed Central

PMC publication ID

6 November 2017

Bruce Berwald

5

1 reference

Europe PubMed Central

PMC publication ID

6 November 2017

Charles Fogarty

6

1 reference

Europe PubMed Central

PMC publication ID

6 November 2017

Terry Poling

7

1 reference

Europe PubMed Central

PMC publication ID

6 November 2017

Dennis Riff

8

1 reference

Europe PubMed Central

PMC publication ID

6 November 2017

Mira Baron

9

1 reference

Europe PubMed Central

PMC publication ID

6 November 2017

Harry Collins

12

1 reference

Europe PubMed Central

PMC publication ID

6 November 2017

Marc Shepard

13

1 reference

Europe PubMed Central

PMC publication ID

6 November 2017

Marc Dionne

14

1 reference

Europe PubMed Central

PMC publication ID

6 November 2017

Daniel Brune

15

1 reference

Europe PubMed Central

PMC publication ID

6 November 2017

Linda Ferguson

16

1 reference

Europe PubMed Central

PMC publication ID

6 November 2017

David Vaughn

17

1 reference

Europe PubMed Central

PMC publication ID

6 November 2017

Ping Li

18

1 reference

Europe PubMed Central

PMC publication ID

6 November 2017

Louis Fries

19

1 reference

Europe PubMed Central

PMC publication ID

6 November 2017

language of work or name

0 references

publication date

1 June 2011

1 reference

Europe PubMed Central

PMC publication ID

6 November 2017

Journal of Infectious Diseases

1 reference

Europe PubMed Central

PMC publication ID

6 November 2017

203

1 reference

Europe PubMed Central

PMC publication ID

6 November 2017

12

1 reference

Europe PubMed Central

PMC publication ID

6 November 2017

1729-1738

1 reference

Europe PubMed Central

PMC publication ID

6 November 2017

Adjuvant System AS03 containing α-tocopherol modulates innate immune response and leads to improved adaptive immunity.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100510

20 June 2018

AS03(A)-Adjuvanted influenza A (H1N1) 2009 vaccine for adults up to 85 years of age.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100510

20 June 2018

Safety and cross-reactive immunogenicity of candidate AS03-adjuvanted prepandemic H5N1 influenza vaccines: a randomized controlled phase 1/2 trial in adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100510

20 June 2018

Immunogenicity and Safety of H5N1 A/Vietnam/1194/2004 (Clade 1) AS03-adjuvanted prepandemic candidate influenza vaccines in children aged 3 to 9 years: a phase ii, randomized, open, controlled study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100510

20 June 2018

Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100510

20 June 2018

Single dose vaccination with AS03-adjuvanted H5N1 vaccines in a randomized trial induces strong and broad immune responsiveness to booster vaccination in adults.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100510

20 June 2018

Priming with AS03 A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: an open non-randomised extension of a double-blind randomised primary study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100510

20 June 2018

Prepandemic H5N1 influenza vaccine adjuvanted with AS03: a review of the pre-clinical and clinical data.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100510

20 June 2018

MF59-adjuvanted H5N1 vaccine induces immunologic memory and heterotypic antibody responses in non-elderly and elderly adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100510

20 June 2018

Stockpiling prepandemic influenza vaccines: a new cornerstone of pandemic preparedness plans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100510

20 June 2018

Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in infants and children.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100510

20 June 2018

Safety and reactogenicity profile of an adjuvanted H5N1 pandemic candidate vaccine in adults within a phase III safety trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100510

20 June 2018

Cross-subtype immunity against avian influenza in persons recently vaccinated for influenza

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100510

20 June 2018

Cross-protection against lethal H5N1 challenge in ferrets with an adjuvanted pandemic influenza vaccine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100510

20 June 2018

Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100510

20 June 2018

Strategies for mitigating an influenza pandemic

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100510

20 June 2018

Immunogenicity of a monovalent, aluminum-adjuvanted influenza whole virus vaccine for pandemic use.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100510

20 June 2018

Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100510

20 June 2018

Detection of anti-H5 responses in human sera by HI using horse erythrocytes following MF59-adjuvanted influenza A/Duck/Singapore/97 vaccine

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR172

21 January 2018

Pre- or post-pandemic influenza vaccine?

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR172

21 January 2018

Effects of repeated annual influenza vaccination on antibody responses against unchanged vaccine antigens in elderly frail institutionalized volunteers.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIR172

21 January 2018

Antigenic and genetic characteristics of H5N1 viruses and candidate H5N1 vaccine viruses developed for potential use as pre-pandemic vaccines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3100510

26 November 2018

The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/21606531

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibody response to influenza vaccine in adults vaccinated with identical vaccine strains in consecutive years

1 reference

https://pubmed.ncbi.nlm.nih.gov/21606531

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1093/INFDIS/JIR172

1 reference

Europe PubMed Central

PMC publication ID

6 November 2017

Internet Archive ID

pubmed-PMC3100510

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

6 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

6 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30403078&oldid=1980519134"